SEC Form 4 · accession 0001178913-18-003093
Foamix Pharmaceuticals Ltd. · FOMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aharon Schwartz
Director
Period of report
Nov 26, 2018
Accepted (ET)
Dec 6, 2018 · 6:09 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606645
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nov 26, 2018 | P | 50,000 | $3.892 | A | 50,000 | D | |
| Ordinary Shares | Nov 27, 2018 | P | 50,000 | $3.916 | A | 100,000 | D | |
| Ordinary Shares | Nov 28, 2018 | P | 12,200 | $3.883 | A | 112,200 | D |
Table II — derivative securities
No Table II lines on this filing.